Related references
Note: Only part of the references are listed.In-Vitro Internalization and In-Vivo Tumor Uptake of Anti-EGFR Monoclonal Antibody LA22 in A549 Lung Cancer Cells and Animal Model
Zhaofei Liu et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Associations between the uptake of In-111-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts
Kristin McLarty et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin αvβ3 PET imaging
Zhaofei Liu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Dual Integrin and Gastrin-Releasing Peptide Receptor Targeted Tumor Imaging Using 18F-labeled PEGylated RGD-Bombesin Heterodimer 18F-FB-PEG3-Glu-RGD-BBN
Zhaofei Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Use of a Novel Arg-Gly-Asp Radioligand, F-18-AH111585, to Determine Changes in Tumor Vascularity After Antitumor Therapy
Matthew S. Morrison et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PET
Hugo J. W. L. Aerts et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Small-Animal PET of Tumors with 64Cu-Labeled RGD-Bombesin Heterodimer
Zhaofei Liu et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Tc-99m-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer
Jiyun Shi et al.
BIOCONJUGATE CHEMISTRY (2008)
Glutathione Peroxidase 2 Inhibits Cyclooxygenase-2-Mediated Migration and Invasion of HT-29 Adenocarcinoma Cells but Supports Their Growth as Tumors in Nude Mice
Antje Banning et al.
CANCER RESEARCH (2008)
Integrin αvβ3-Targeted Radioimmunotherapy of Glioblastoma Multiforme
Anand Veeravagu et al.
CLINICAL CANCER RESEARCH (2008)
Integrin αvβ3-Targeted Cancer Therapy
Zhaofei Liu et al.
DRUG DEVELOPMENT RESEARCH (2008)
Imaging liver metastases of colorectal cancer patients with radiolabelled bevacizumab: Lack of correlation with VEGF-A expression
Marian G. W. Scheer et al.
EUROPEAN JOURNAL OF CANCER (2008)
90Y-Ibritumomab Therapy in Refractory Non-Hodgkin's Lymphoma: Observations from 111In-Ibritumomab Pretreatment Imaging
Andrei Iagaru et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591:: Lesion detectability and dosimetric projections for 90Y Radioimmunotherapy
Neeta Pandit-Taskar et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
In vivo gamma imaging of the secondary tumors of transplanted human fetal striatum neural stem cells-derived primary tumor cells
Qihua He et al.
NEUROREPORT (2008)
Phase I and pharmacokinetic study of etaracizumab (Abegrin™), a humanized monoclonal antibody against αvβ3 integrin receptor, in patients with advanced solid tumors
Catherine Delbaldo et al.
INVESTIGATIONAL NEW DRUGS (2008)
[18F]Galacto-RGD positron emission tomography for imaging of αvβ3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck
Ambros J. Beer et al.
CLINICAL CANCER RESEARCH (2007)
[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues
Adam F. Prasanphanich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Inhibition of human tumor xenograft growth in nude mice by a conjugate of monoclonal antibody LA22 to epidermal growth factor receptor with anti-tumor antibiotics mitomycin C
Wei Shao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
In vitro and in vivo characterization of 64Cu-labeled Abegrin™ a humanized monoclonal antibody against integrin αvβ3
Weibo Cai et al.
CANCER RESEARCH (2006)
Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes
CA Boswell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Preparation and biological evaluation of copper-64-labeled Tyr3 -: Octreotate using a cross-bridged macrocyclic chelator
JE Sprague et al.
CLINICAL CANCER RESEARCH (2004)
Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications
H Maeda et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Integrin αvβ3 as a therapeutic target for blocking tumor-induced angiogenesis
CC Kumar
CURRENT DRUG TARGETS (2003)
A pilot trial of vitaxin, a humanized anti-vitronectin receptor (anti αvβ3) antibody in patients with metastatic cancer
JA Posey et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2001)
Share Paper
